Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients

被引:0
作者
Maxime Fontanilles
Florent Marguet
Cristina Alexandru
Olivier Langlois
Ovidiu Veresezan
Vianney Gilard
Marion David
Annie Laquerriere
Chantal Hanzen
Isabelle Tennevet
Frédéric Di Fiore
Florian Clatot
机构
[1] Rouen University Hospital,Normandie Univ, UNIROUEN, Inserm U1245, IRON group, Normandy Centre for Genomic and Personalized Medicine
[2] Cancer Centre Henri Becquerel,Department of Medical Oncology
[3] Rouen University Hospital,Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Department of Pathology
[4] Rouen University Hospital,Department of Neurosurgery
[5] Cancer Centre Henri Becquerel,Department of Radiation Oncology and Medical Physics
[6] Cancer Centre Henri Becquerel,Department of Biopathology
[7] Rouen University Hospital,Department of Hepatogastroenterology
来源
Supportive Care in Cancer | 2019年 / 27卷
关键词
Glioblastoma; Temozolomide; Thrombocytopenia; Early platelet variation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:477 / 484
页数:7
相关论文
empty
未找到相关数据